Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
J.&J.’s Next Chief Is Steeped in Sales Culture
J.&J.’s Next Chief Is Steeped in Sales Culture
NY Times, NY
JNJ
Pharma CEOs
Alex Gorsky
FDA panel recommends Chelsea Therapeutics drug
FDA panel recommends Chelsea Therapeutics drug
Reuters
FDA
advisory panels
Chelsea Therapeutics
Northera
U.S. panel backs Forest Labs drug for smoker's cough
U.S. panel backs Forest Labs drug for smoker's cough
Reuters
Forest Labs
COPD
Almirall
aclidinium bromide
An Overview Of 4 Drug Manufacturers Yielding Over 4%
An Overview Of 4 Drug Manufacturers Yielding Over 4%
Seeking Alpha
Eli Lilly
Merck
Pfizer
Bristol-Myers Squibb
Drug Companies Feel Price Pressure
Drug Companies Feel Price Pressure
NY Times, NY
drug pricing
J&J Recall: Manufacturing issues believed behind CEO departure
J&J Recall: Manufacturing issues believed behind CEO departure
Fierce Pharma Manufacturing
recalls
JNJ
William Weldon
Pharma CEOs
MannKind Narrows Loss
MannKind Narrows Loss
Yahoo/Zacks
earnings
MannKind
The Battle For The Anti-Coagulation Market
The Battle For The Anti-Coagulation Market
Seeking Alpha
anticoagulants
Pfizer
Sanofi
Bristol-Myers Squibb
Chelsea Therapeutics: FDA Panel Live Blog
Chelsea Therapeutics: FDA Panel Live Blog
TheStreet.com
FDA
advisory panels
Chelsea Therapeutics
Northera
4 Compelling Alternatives To Vertex Pharma
4 Compelling Alternatives To Vertex Pharma
Seeking Alpha
Vertex Pharmaceuticals
Acorda
Aveo Pharmaceutical
Jazz Pharmaceuticals
Momenta
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »